Pharmaceutical Intermediates Market OverviewThe global pharmaceutical intermediates market is witnessing steady expansion as pharmaceutical manufacturing scales worldwide. Valued at approximately USD ...

We are very much confident that we will be able to achieve our guidance of 20 percent plus growth in revenue, Managing ...

Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...

After the U.S. tariff imposition, policymakers must diversify boldly, reform swiftly, and secure India’s pharma supremacy ...

Bengaluru: Karnataka is at the forefront of science and pharmaceutical research, and the union government should establish a ...

The government has banned the manufacture, sale and distribution of all oral formulations of pain and fever medications, ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best affordable healthcare stocks to buy now. On December 22, ...

In a milestone development Monday, the Food and Drug Administration green-lit an oral version of the obesity treatment Wegovy ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump’s “most ...

The White House Fact Sheet recognizes that marijuana has a "currently accepted medical use" and notes that the lack of FDA approval leaves six million registered patients and 30,000 practitioners ...

Pharmanoid is a manufacturing site specializing in the production of HPAPIs for ophthalmology. Inke, which is backed by Keensight Capital, has acquired Pharmanoid from Gentec Pharmaceutical Group.